OCLG Continues Pursuit of Debt Reduction and Increasing Shareholder Value
(firmenpresse) - LAFAYETTE, LA -- (Marketwired) -- 02/24/15 -- (OTC PINK: OCLG)
Wayne Erwin, OCLG''s Chief Executive Officer, remarked, "We continue on our mission to increase shareholder value by reducing the gross amount of convertible notes outstanding and, more importantly, prior to their conversion. Our corporate strategy is to retire all notes prior to their conversion dates and this most recent payoff eliminated the issuance of approximately 7 million shares of our common stock."
Mr. Erwin further commented, "Over the past several months we have retired similar convertible notes, eliminating the issuance of over 55 million shares by utilizing our operational cash flows. This strategy benefits the company in multiple ways including reducing shareholder dilution and our overall corporate debt. This proactive management strategy furthers our corporate mission to deliver upon increased shareholder values."
Oncologix is a diversified medical holding company that operates and manufactures Class II medical device products, delivers Personal Health Care Services, and sells and distributes Durable and Home Medical Equipment. For its clients, Oncologix provides FDA approved medical devices, state licensed healthcare services, and medical products and technologies. For its shareholders, Oncologix operates profitable divisions that build, maintain and nourish shareholder value. The Company''s corporate mission is to be the best small cap medical holding company in North America.
This press release may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Company''s expectations, among other things, are dependent upon economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, its ability to operate its subsidiary companies effectively, need for and availability of more capital as well as other uncontrollable or unknown factors which are more fully disclosed in the Company''s filings with the Securities and Exchange Commission.
Wayne Erwin
Chairman and CEO
Green Arrow Consulting LLC
(850) 733-9181
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.02.2015 - 08:26 Uhr
Sprache: Deutsch
News-ID 1339480
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
LAFAYETTE, LA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 146 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"OCLG Continues Pursuit of Debt Reduction and Increasing Shareholder Value
"
steht unter der journalistisch-redaktionellen Verantwortung von
Oncologix Tech, Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
